Lipodystrophy：治療薬のグローバル治験動向（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Lipodystrophy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Lipodystrophy 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Lipodystrophy Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Lipodystrophy 31
May 06, 2013: Bristol-Myers Squibb And AstraZeneca Announce Positive Results From Sub-Group Analysis Of Metreleptin In Pediatric Patients With Lipodystrophy 31
Apr 15, 2011: Amylin To Present Data Showing Investigational Metreleptin Treatment Led To Long-Term Improvements In Diabetes And Lipid Control In Patients With Lipodystrophy 32
Jul 18, 2007: Theratechnologies TH9507 Phase III Clinical Update At International HIV Meeting 32
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Bristol-Myers Squibb Company 34
Clinical Trial Overview of Bristol-Myers Squibb Company 34
Theratechnologies Inc. 35
Clinical Trial Overview of Theratechnologies Inc. 35
Gilead Sciences, Inc. 36
Clinical Trial Overview of Gilead Sciences, Inc. 36
Merck KGaA 37
Clinical Trial Overview of Merck KGaA 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Sigma-Tau S.p.A. 39
Clinical Trial Overview of Sigma-Tau S.p.A. 39
Eli Lilly and Company 40
Clinical Trial Overview of Eli Lilly and Company 40
Cryopraxis Criobiologia Ltda 41
Clinical Trial Overview of Cryopraxis Criobiologia Ltda 41
AbbVie Inc. 42
Clinical Trial Overview of AbbVie Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
The National Institute of Allergy and Infectious Diseases 43
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 43
The National Institute of Diabetes and Digestive and Kidney Diseases 44
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 44
The University of Texas Southwestern Medical Center at Dallas 45
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 45
French National Agency for Research on AIDS and Viral Hepatitis 46
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 46
The Kirby Institute 47
Clinical Trial Overview of The Kirby Institute 47
Massachusetts General Hospital 48
Clinical Trial Overview of Massachusetts General Hospital 48
Queen’s University 49
Clinical Trial Overview of Queen’s University 49
Beth Israel Deaconess Medical Center 50
Clinical Trial Overview of Beth Israel Deaconess Medical Center 50
Kyoto University 51
Clinical Trial Overview of Kyoto University 51
Hvidovre University Hospital 52
Clinical Trial Overview of Hvidovre University Hospital 52
Five Key Clinical Profiles 53
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 111